Prime Medicine, Inc. (PRME) SEC Filings — 2024
20 SEC filings for Prime Medicine, Inc. (PRME) in 2024.
Filings
- Arch Venture Fund XII Amends Stake in Prime Medicine — SC 13D/A · Nov 22, 2024
- Prime Medicine Files 8-K on Financials — 8-K · Nov 12, 2024
- Prime Medicine, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Prime Medicine Files 8-K — 8-K · Oct 24, 2024
- Prime Medicine, Inc. SC 13G Filing — SC 13G · Oct 4, 2024
- Prime Medicine Files 8-K: Agreements, Sales, and Financials — 8-K · Sep 30, 2024
- Prime Medicine Files 8-K on Financials — 8-K · Aug 8, 2024
- Prime Medicine Files 8-K — 8-K · Jun 12, 2024
- Prime Medicine Files 8-K with Corporate Updates — 8-K · May 21, 2024
- Prime Medicine, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 10, 2024
- Prime Medicine, Inc. Announces 2024 Annual Meeting of Stockholders on June 12, 2024 — DEF 14A · Apr 29, 2024
- Prime Medicine, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 1, 2024
- Prime Medicine, Inc. SC 13G/A Filing — SC 13G/A · Feb 29, 2024
- ARCH Venture Funds Disclose Stake in Prime Medicine — SC 13D · Feb 22, 2024
- Prime Medicine Enters Material Definitive Agreement — 8-K · Feb 16, 2024
- Prime Medicine Files 8-K on Financial Condition — 8-K · Feb 14, 2024
- GV 2019, L.P. Amends Prime Medicine Stake (SC 13G/A) — SC 13G/A · Feb 9, 2024
- FMR LLC & Abigail Johnson Maintain 9.338% Stake in Prime Medicine — SC 13G/A · Feb 9, 2024
- Prime Medicine Confirms Emerging Growth Company Status — 8-K · Jan 8, 2024
- Prime Medicine Reports Officer/Director Changes & Comp Arrangements — 8-K · Jan 5, 2024